NDAINJECTIONINJECTABLE
Approved
Feb 1979
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
GALLIUM CITRATE GA 67 (gallium citrate ga-67) by Curium Pharma is clinical pharmacology gallium citrate ga 67, with no carrier added, has been found to concentrate in certain viable primary and metastatic tumors as well as focal sites of infection. First approved in 1979.
Drug data last refreshed 23h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Gallium Citrate GA-67 is a radioactive diagnostic imaging agent (radiopharmaceutical) administered by intravenous injection. It concentrates in viable tumors and focal infection sites, with unknown mechanism of action but evidence of lysosomal accumulation and binding to soluble intracellular proteins. The agent is used for scintigraphic imaging to detect and localize primary and metastatic tumors as well as sites of infection.
LOE Approaching
Product lifecycle approaching loss of exclusivity with moderate competitive pressure (30%), indicating defensive strategy and potential team downsizing or repositioning.
Mechanism of Action
CLINICAL PHARMACOLOGY Gallium Citrate Ga 67, with no carrier added, has been found to concentrate in certain viable primary and metastatic tumors as well as focal sites of infection. The mechanism of concentration is unknown, but investigational studies have shown that gallium Ga-67 accumulates in…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Gallium Citrate GA-67 represents a career opportunity in legacy product management and defensive commercialization within diagnostic radiopharmaceuticals. Positions are limited and focused on market maintenance rather than growth, requiring strategic planning for competitive and regulatory challenges.
Worked on GALLIUM CITRATE GA 67 at Curium Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.